Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 479

Eli Lilly injects $53m into CureVac

The equity investment is part of a cancer vaccine development deal between the companies that could eventually reach more than $1.7bn in size.

Oct 19, 2017

Aventamed tunes up $2.1m investment

The cash will allow Aventamed to seek regulatory approvals to sell its Solo earplant device in the US, having already launched in European markets.

Oct 19, 2017

Heliatek re-energises with new funding

BASF, Engie and Innogy were among the investors that provided $17.6m in funding for the solar film developer, a year after doing the same for its series D round.

Oct 18, 2017

Connexin secures up to $13m

The wireless internet provider has secured an investment from Cisco backed Digital Alpha to expand its team and fund a new technology centre.

Oct 18, 2017

UK watchdog clears Touchstone-IP Group merger

The Competition & Markets Authority decision has allowed IP Group to confirm that its offer will become unconditional on November 9.

Oct 17, 2017

UIC participants eye European horizon

The EuroIncNet partnership between UIC and four other Europe-based incubators means Sweden-based spinouts could be doing business in Austria, the Netherlands, Belgium or Italy.

Oct 16, 2017

InflaRx inhales $55m in series D round

Bain Capital Life Sciences, Cormorant Asset Management and RA Capital co-led the Staidson-backed inflammatory disease drug developer's latest round.

Oct 16, 2017
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here